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Expanding Available Pyrazole Substitution Patterns by Sydnone Cycloaddition 
Reactions 
A. W. Brown and J. P. A. Harrity* 
Department of Chemistry, University of Sheffield, Sheffield, S3 7HF (U.K.). j.harrity@sheffield.ac.uk 
Abstract 
We report the use of alkynylsilanes for the regiocontrolled synthesis of pyrazoles from 
functionalised sydnones. The strategies outlined herein allow a range of pyrazoles to be 
accessed with substitution patterns that are otherwise not directly obtained with high 
selectivity by alkyne cycloadditions. Moreover, this study serendipitously highlighted a 
simple and convenient procedure for the synthesis of aryl monofluoromethyl ethers through 
the combination of TBAF and dichloromethane. 
 
Introduction 
Pyrazoles are a privileged class of heteroaromatic compounds and they constitute the core 
motif of a number of compounds of medicinal and agrochemical significance.1 Classical 
approaches to pyrazoles have broadly encompassed condensation and cycloaddition 
reactions.2 Work in our labs has sought to exploit both strategies for the direct formation of 
borylated pyrazoles where the borate is introduced during annelation, rather than through ring 
functionalisation.3 With respect to cycloadditions, sydnones have emerged as effective 
precursors to pyrazoles, and they offer a regiocontrolled route to 1,3-disubstituted and 1,3,5-
trisubstituted diazoles when reacted with terminal alkynes.4 This product substitution pattern 
is the result of the innate selectivity of alkyne cycloadditions with 4-H and 4-substituted 
sydnone substrates. We have been interested in developing strategies that overturn this innate 
selectivity, and report herein how alkynylsilanes can access alternative substitution patterns, 
thereby expanding the scope of sydnone cycloaddition methodology for pyrazole synthesis 
(Scheme 1).5 
Page 2 
 
 
Scheme 1. Sydnone cycloadditions of alkynes to form pyrazoles. 
Results and Discussion 
1,5-Disubstituted pyrazoles: We initially started our investigations into expanding the scope 
of the preparation of 1,5-disubstituted pyrazoles. Our strategy was to employ 
trimethylsilylacetylene as a non-gaseous acetylene equivalent in cycloaddition reactions of 4-
substituted sydnones, which were in turn prepared by direct arylation6 or by metalation 
chemistry. In all cases attempted, the cycloaddition proceeded efficiently and with high 
(albeit ultimately inconsequential) regioselectivity favouring the 3-substituted pyrazole 
(Scheme 2). In contrast, TBAF-mediated removal of the trimethylsilyl group proved 
somewhat less general. While pyrazoles 2, 4 and 8 were successfully prepared in good yield 
(see below for discussion of compound 10), Weinreb amide-substituted pyrazole 5 only 
afforded a complex mixture of products. Moreover, in the case of oxazoline-substituted 
pyrazole 11, product 12 was afforded in only moderate yield. 
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Scheme 2. Preparation of 1,5-disubstituted pyrazoles. aR2 in the starting sydnone was used as 
the corresponding TBS-ether. 
These studies highlighted some unexpected outcomes in the TBAF mediated 
protodesilylation of 3-trimethylsilylpyrazoles. With regard to the low yield observed in the 
synthesis of 12, we were able to isolate (23%, 1:1 E:Z) and characterise a major by-product 
of this reaction which proved to be nitrile 13 (Scheme 3). The isolation and characterisation 
of 13 highlights the propensity of electron deficient pyrazoles to undergo elimination under 
strongly basic conditions.7 
 
Scheme 3. TBAF-mediated elimination. 
With regard to the conversion of 9ĺ10, we noted that significantly lower yields of product 
were observed in the presence of CH2Cl2 (carried over from chromatography). Specifically, 
when 9 was subjected to refluxing TBAF, a small amount of 10 was isolated together with 
mono-fluoromethylated phenol 14. In addition, fluoromethylation product 14 could be 
generated in higher yield when the reaction vessel was charged with dichloromethane, TBAF 
and heated at reflux (Scheme 4). 
 
Scheme 4. TBAF-mediated protodesilylation and monofluoromethylation studies. 
TMP:3,4,5-(MeO)3C6H2. 
Current interest in developing methods for the simple incorporation of fluorous hydrocarbons 
suggested that this method could represent a powerful tool in the synthesis of organofluorine 
compounds. Monofluoromethyl ethers are much less prevalent in the literature than their 
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difluoro- and trifluoro- counterparts. However, Hu et al. recently reported the 
monofluoromethylation of phenols and other nucleophiles using fluoroalkyl sulfoximines.8 In 
order to explore the generality of our method for the synthesis of monofluoromethyl ethers, 
we attempted to repeat the reaction shown in Scheme 4 on 4-bromophenol and 3-hydroxy-4-
methoxybenzaldehyde, our results are depicted in Scheme 5. Subjecting 4-bromophenol to 
TBAF/CH2Cl2 led to fluoromethylation product 15, as judged by 1H NMR analysis of the 
crude reaction mixture. However, the product was found to be contaminated with the 
corresponding acetal 16. Unfortunately, 15 and 16 could not be separated by 
chromatography. Furthermore, 15 was found to undergo conversion to acetal 16 on various 
chromatographic supports, or on standing. In this context, the instability of 
monofluoromethyl ethers has been noted by Hu and Sheng.8,9 Interestingly however, 17 could 
be isolated cleanly after chromatography on florisil, albeit in modest yield (Scheme 5). These 
experiments suggested that the fluoromethyl ether formation outlined here may be useful, but 
only in cases where the final products undergo slow hydrolysis. Finally, with regard to the 
mechanism of fluoromethyl ether formation, Zhang et al. have shown that 
chlorofluoromethane is capable of alkylating phenols.10 We therefore propose that CH2Cl2 
and TBAF combine to form FCH2Cl as an alkylating agent. The potential for 
fluoromethylation via an interrupted Reimer-Tiemann reaction11 was discounted as CD2Cl2 
provided the d-17 with >95% D-incorporation. 
 
Scheme 5. TBAF-mediated monofluoromethylation of phenols. 
 
1,4,5-Trisubstituted pyrazoles: We next turned our attention to the synthesis of more heavily 
decorated pyrazoles. We envisaged that an alkynylboronate bearing a trimethylsilyl group 
could provide general access to 1,4,5-substituted products, assuming appropriate 
regiochemical insertion of the alkyne. Specifically, the TMS-group could act as a surrogate 
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for a C3-H while the boronate would offer a means for diversifying at C4. Our results 
towards this objective are summarised in Scheme 6. The cycloaddition reactions generally 
proceeded in moderate to good yield and afforded single regioisomers in the cases of 18, 21, 
and 27, in a similar manner to our previous report on alkynylboronate cycloadditions.3(b),(c) 
Interestingly, slightly lower regioselectivities were observed for products 24 and 30, possibly 
due to the electron rich nature of the sydnone 4-substituents in these cases. Suzuki-Miyaura 
coupling of the cycloadducts proceeded smoothly for all examples, affording fully-substituted 
pyrazole cores. TBAF-mediated TMS cleavage successfully furnished products 23, 29 and 
32, although a particularly low yield was isolated in the case of 26. Unfortunately, 19 was not 
a viable substrate for this final step and desilylation resulted in a complex mixture of 
products. 
 
Scheme 6. Preparation of 1,4,5-disubstituted pyrazoles. 
 
Regiocontrolled 3,4-substituted pyrazole synthesis: Generally speaking, the employment of 
internal alkynes in sydnone cycloadditions results in a mixture of pyrazole regioisomers.12 
While this issue is somewhat alleviated by the employment of alkynylboronates, sydnones 
with a C4-substituent are typically required.3(c) As terminal alkynes generally undergo highly 
regioselective cycloadditions with sydnones, we envisioned that a bromination and cross-
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coupling sequence would represent a more controlled and predictable strategy for the 
synthesis of 1,3,4- and 1,3,4,5-substituted pyrazoles. In order to investigate this approach, we 
subjected a small series of N-arylsydnones to cycloaddition, and these afforded 33, 35 and 37 
in good to high yield and high regioselectivity (Scheme 7). The cycloadducts were then 
brominated and immediately subjected to Suzuki-Miyaura cross-coupling with boronic acid 
derivatives. Gratifyingly, the 1,3,4-trisubsubstituted pyrazoles 34, 36 and 38 were isolated in 
moderate to good yield. Furthermore, 4-substituted sydnones underwent cycloaddition with 
terminal alkynes with excellent regioselectivity. In the case of the oxazine-substituted 
sydnone, a significant amount of decomposition was observed resulting in a very low isolated 
yield of pyrazole 39. Subsequent bromination and cross-coupling afforded fully-substituted 
pyrazoles 40, 42 and 46, albeit with generally low yields because of steric hindrance. 
Unfortunately, Weinreb amide 43 was not stable to the bromination/Suzuki-Miyaura strategy. 
Overall this strategy provides rapid access to fully-substituted pyrazole cores bearing useful 
functionality, with near complete control of regiochemistry. A quite diverse range of 
structures can be installed with predictable regiochemistry. 
 
Scheme 7. Preparation of 1,3,4-trisubstituted- and 1,3,4,5-tetrasubstituted pyrazoles. 
Conclusions 
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We have developed a flexible strategy for the synthesis of a diverse range of pyrazoles with 
high and predictable regiocontrol. A range of functional groups are tolerant of the 
cycloaddition conditions and a number of functionalised pyrazoles have been prepared. These 
studies have highlighted the potential of TBAF-CH2Cl2 mixtures to transfer fluoromethyl 
groups, although the generality of this process appears to be narrow at present due to 
instability in the resulting products.  
Experimental Section 
General Procedure A: Preparation of 3,4-diarylsydnones: 
A mixture of sydnone (1 eq.), aryl halide (1.5 eq.), palladium acetate (5 mol %), XPhos (10 
mol %) and potassium carbonate (2-3 eq.) in DMF (0.25 ± 0.5 M) under an atmosphere of 
nitrogen was heated at 80 - 120 qC for 14 hours before the reaction was allowed to cool to 
ambient temperature and water was added. The resulting mixture was extracted with ethyl 
acetate:40-60 petroleum ether (9:1) and the combined organic layers dried over MgSO4 and 
concentrated in vacuo. Flash silica chromatography (eluting solvent 20%-100% ethyl acetate 
in 40-60 petroleum ether) afforded the target 3,4-diarylsydnones. The compounds could be 
further purified by recrystallisation from ethanol or dichloromethane/petrol. 
General Procedure B: Cycloadditions of Sydnones with Terminal Alkynes: 
A Schlenk tube was charged with sydnone (1 eq.), alkyne (2-4 eq.) and xylenes (1 M). The 
tube was then sealed and heated at 160 RC for 24 hours. The mixture was allowed to cool to 
ambient temperature and loaded onto a short plug of silica and washed with 40-60 petroleum 
ether before elution with ethyl acetate. Volatiles were removed in vacuo and the crude 
residue purified by flash silica chromatography (gradient starting with 100% 40-60 petroleum 
ether and ending with 40% ethyl acetate in 40-60 petroleum ether) affording the target 1,3,5-
trisubstituted pyrazoles as major products. 
 
 
 
 
General Procedure C: Trimethylsilyl Group Cleavage: 
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A flask equipped with a reflux condenser was charged with pyrazole (1 eq.), and TBAF (10 
eq. 1 M solution in THF) and heated at reflux under an inert atmosphere of nitrogen for 24 
hours. The mixture was allowed to cool to ambient temperature, poured into water and 
extracted with ethyl acetate. The combined organic layers were dried over MgSO4 and 
concentrated in vacuo. Flash silica chromatography (gradient starting with 100% 40-60 
petroleum ether and ending with 60% ethyl acetate in 40-60 petroleum ether) afforded the 
target desilated pyrazoles. 
General Procedure D: Thermal Cycloaddition of Sydnones with Alkynylboronates: 
A Schlenk tube was charged with sydnone (1 eq.), alkyne (2 eq.) and xylenes (1 M). The tube 
was then sealed and heated at 180 RC for 48 hours. The mixture was allowed to cool to 
ambient temperature and loaded onto a short plug of silica and washed with 40-60 petroleum 
ether before elution with ethyl acetate. Volatiles were removed in vacuo and the crude 
residue purified by flash silica chromatography (gradient starting with 100% 40-60 petroleum 
ether and ending with 40% ethyl acetate in 40-60 petroleum ether) affording the target 
pyrazole boronic esters. The products were isolated as single regioisomers unless otherwise 
stated and contaminated with small amounts of protodeboronated by-product. 13C NMR 
spectra of organoboron compounds are missing a signal for the carbon atom directly attached 
to the boron due to broadening arising from the quadrupolar relaxation effect. 
General Procedure E: Suzuki-Miyaura Coupling of Pyrazole Boronic Acid Derivatives:  
A flask equipped with a reflux condenser was charged with pyrazole boronic ester (1 eq.), 
XPhosPdG2 (0.1 eq.), sodium carbonate (2 eq.) and degassed 1,2-dimethoxyethane:water 
(1:1, 0.1 M) and heated at 80 RC under an inert atmosphere of nitrogen for 14 hours. The 
mixture was allowed to cool to ambient temperature, poured into water and extracted with 
ethyl acetate. The combined organic layers were dried over MgSO4 and concentrated in 
vacuo. Flash silica chromatography (gradient starting with 100% 40-60 petroleum ether and 
ending with 40% ethyl acetate in 40-60 petroleum ether) afforded the target cross-coupled 
pyrazoles as an inseparable mixture of the target material and the product arising from 
protodeboronation. Only characterisation for the target material is reported. 
General Procedure F: Bromination and Subsequent Suzuki-Miyaura Coupling of Pyrazoles: 
To a flask containing pyrazole (1 eq.) was added a solution of N-bromosuccinamide (1 eq.) in 
acetonitrile (0.2 M). The resulting mixture was stirred for one hour at ambient temperature, 
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before being poured into water. The mixture was extracted with ethyl acetate and the 
combined organic layers washed with aqueous sodium hydroxide (1 M). The organic layer 
was dried over MgSO4, filtered and volatiles removed in vacuo. The crude material was 
concentrated into a flask. The flask was then charged with aryl/vinyl boronate (1.5 eq.), 
XPhosPdG2 (10 mol %), sodium carbonate (2-3.5 eq.) and thoroughly degassed 1,2-
dimethoxyethane:water (1:1, 0.1 M). The mixture was heated at 80 RC for 14 hours, cooled to 
ambient temperature, poured into water and extracted with ethyl acetate. The combined 
organic layers were dried over MgSO4, filtered and volatiles removed in vacuo. Flash silica 
chromatography (gradient starting with 100% 40-60 petroleum ether and ending with 100% 
ethyl acetate in 40-60 petroleum ether) afforded the target pyrazoles. 
N-Methyl-, N-benzyl-, N-phenyl-, N-(4-methoxyphenyl)-, N-(4-fluorophenyl)-, and N-(3,4,5-
trimethoxyphenyl)sydnone were prepared by standard methods (cyclodehydration of N-
nitrosoamino acid with trifluoroacetic anhydride).6 4-(4-tolyl)-N-methylsydnone1 and 4-(4-
tolyl)-N-phenylsydnone6 were prepared according to procedures described previously. 
4-(3,4,5-Trimethoxyphenyl)-N-(4-methoxyphenyl)sydnone:  
Following general procedure A using N-(4-methoxyphenyl)sydnone (100 mg, 0.521 mmol) 
and 5-bromo-1,2,3-trimethoxybenzene (193 mg, 0.781 mmol), the title compound was 
isolated as a yellow solid (132 mg, 71%).  
M.p.: 155-157 qC (dec.); 1H NMR (400 MHz, CDCl3į+V+V+
s), 6.55 (2H, s), 7.06 (2H, d, J = 9.0 Hz), 7.44 (2H, d, J = 9.0 Hz); 13C NMR (101 MHz, 
CDCl3 į            
)7,5Ȟmax 3116 (w), 3091 (w), 2944 (w), 2841 (w), 1729 (s), 1578 (s), 1125 (s), 991 
(m); HRMS calculated for C18H19N2O6 (ES+)(+H+): 359.1243. Found: 359.1239.  
1-(4-Methoxyphenyl)-3-(trimethylsilyl)-5-(3,4,5-trimethoxyphenyl)-pyrazole, 1a and 1-(4-
methoxyphenyl)-4-(trimethylsilyl)-5-(3,4,5-trimethoxyphenyl)-pyrazole 1b:  
Following general procedure B using 4-(3,4,5-trimethoxyphenyl)-N-(4-
methoxyphenyl)sydnone (200 mg, 0.558 mmol) and trimethylsilylacetylene (219 mg, 2.23 
mmol) in xylenes (0.56 mL), an inseparable mixture of pyrazole 1a and 1b was isolated as a 
brown oil (230 mg, 100%, 95:5).  
1H NMR (400 MHz, CDCl3į+V+V+V+V+
s),  6.57 (1H, s), 6.87 (2H, d, J = 9.0 Hz), 7.26 (2H, d, J = 9.0 Hz); 13C NMR (101 MHz, 
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CDCl3į-0.8, 55.7, 56.1, 61.1, 106.1, 113.3, 114.2, 126.3, 127.1, 133.8, 137.8, 143.1, 153.1, 
)7,5Ȟmax  2955 (w), 2835 (w), 1584 (m), 1514 (s), 1244 (s), 1125 (s); HRMS 
(ESI-TOF) m/z [M+H]+ calculated for C22H29N2O4Si: 413.1897. Found: 413.1905. 
1-(4-Methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-pyrazole, 2:  
Following general procedure C using a mixture of pyrazoles 1a and 1b (222 mg, 0.539 mmol, 
95:5) and and TBAF in THF (5.4 mL, 5.4 mmol), pyrazole 2 was isolated as an orange solid 
(137 mg, 75%). 
M.p.: 92-94 RC; 1H NMR (400 MHz, CDCl3į+V+V+V
(2H, s),  6.47 (1H, d, J = 2.0 Hz), 6.87 (2H, d, J = 9.0 Hz), 7.23 (2H, d, J = 9.0 Hz), 7.67 (1H, 
d, J = 2.0 Hz); 13C NMR (101 MHz, CDCl3į
126.9, 133.5, 138)7,5Ȟmax  2931 (w), 2835 (w), 1586 (m), 
1514 (s), 1415 (m), 1241 (s), 1121 (s), 1002 (m), 835 (s); HRMS (ESI-TOF) m/z [M+H]+ 
calculated for C19H21N2O4: 341.1501. Found: 341.1504. 
4-(3-Amino-4-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)sydnone: 
Following general procedure A using N-(3,4,5-trimethoxyphenyl)sydnone (100 mg, 0.396 
mmol) and 5-bromo-2-methoxyaniline (120 mg, 0.595 mmol), the title compound was 
isolated as an orange solid (135 mg, 91%).  
M.p.: 173-174 qC; 1H NMR (400 MHz, CDCl3į + V  + V  + V
3.90 (3H, s), 6.52 (1H, dd, J = 8.5, 2.0 Hz), 6.64 (1H, d, J = 8.5 Hz), 6.68 (2H, s), 6.85 (1H, 
d, J = 2.0 Hz); 13C NMR (101 MHz, CDCl3į
)7,5Ȟmax 3471 (w), 3367 (w), 2941 
(w), 2838 (w), 1732 (s), 1606 (m), 1224 (s), 1127 (s); HRMS calculated for C18H20N3O6 
(ES+)(+H+): 374.1352. Found: 374.1353.  
1-(3,4,5-Trimethoxyphenyl)-3-(trimethylsilyl)-5-(3-amino-4-methoxyphenyl)-pyrazole, 3a 
and 1-(3,4,5-trimethoxyphenyl)-4-(trimethylsilyl)-5-(3-amino-4-methoxyphenyl)-pyrazole, 
3b:  
Following general procedure B using 4-(3-amino-4-methoxyphenyl)-N-(3,4,5-
trimethoxyphenyl)sydnone (150 mg, 0.402 mmol) and trimethylsilylacetylene (158 mg, 1.61 
mmol), an inseparable mixture of pyrazole 3a and 3b was isolated as a brown oil (156 mg, 
91%, 95:5).  
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1H NMR (400 MHz, CDCl3į + V + V3.76-3.81 (8H, m), 6.50 (1H, s),  
6.53-6.58 (3H, m), 6.62 (1H, d, J = 2.0 Hz), 6.67 (1H, d, J = 8.5 Hz); 13C NMR (101 MHz, 
CDCl3į-0.9, 55.6, 56.1, 61.0, 103.2, 110.1, 113.5, 115.1, 119.1, 123.7, 136.1, 136.3, 137.1, 
)7,5Ȟmax 3465 (br), 3372 (br), 2955 (w), 2836 (w), 1598 (m), 
1505 (s), 1455 (m), 1418 (m), 1228 (s), 1125 (s), 980 (m), 835 (s); HRMS (ESI-TOF) m/z 
[M+H]+ calculated for C22H30N3O4Si: 428.2006. Found: 428.2023. 
1-(3,4,5-Trimethoxyphenyl)-5-(3-amino-4-methoxyphenyl)-pyrazole, 4:  
Following general procedure C using a mixture of pyrazoles 3a and 3b (156 mg, 0.365 
mmol) and TBAF in THF (3.7 mL, 3.7 mmol), pyrazole 4 was isolated as a tan crystals (99 
mg, 76%). 
M.p.: 100-101 RC; 1H NMR (400 MHz, CDCl3į+V+EU+V
3.84 (3H, s), 6.40 (1H, d, J = 2.0 Hz), 6.56 (2H, s), 6.58 (1H, dd, J = 8.5, 2.0 Hz), 6.64 (1H, 
d, J = 2.0 Hz), 6.70 (1H, d, J = 8.5 Hz), 7.66 (1H, d, J = 2.0 Hz); 13C NMR (101 MHz, 
CDCl3 į    102.8, 107.4, 110.2, 115.2, 119.3, 123.5, 136.2, 136.2, 137.1, 
)7,5Ȟmax 3444 (w), 3346 (w), 3303 (w), 3198 (w), 2934 (w), 
2837 (w), 1598 (m), 1500 (s), 1463 (s), 1419 (s), 1229 (s), 1120 (s), 1029 (m), 991 (m); 
HRMS (ESI-TOF) m/z [M+H]+ calculated for C19H22N3O4: 356.1610. Found: 356.1615. 
4-Carboxylic acid-N-phenylsydnone:13  
To a solution of N-phenylsydnone (3.55 g, 21.9 mmol) in THF (75 mL) at -78 RC was added 
a solution of n-butyl lithium (~2.17 M in hexanes, 11.1 mL, 24.1 mmol). The reaction 
mixture was stirred for 1 hour at -78 RC. The resulting solution was transferred by cannula to 
a flask containing excess solid CO2 and stirred for 1 hour at -78 RC. The reaction was allowed 
to warm to room temperature (caution extra venting required) and stirred for a further 2 
hours. The reaction was poured into water and the aqueous layer washed with ethyl acetate. 
The aqueous layer was then acidified to pH 1 and extracted with ethyl acetate. The combined 
organic layers were dried over MgSO4, filtered, and volatiles removed in vacuo to afford the 
title compound as an orange solid (4.11 g, 91%). The product could be further purified by 
recrystallisation from ethanol.  
M.p.: 190-191 qC (lit.13 193 RC); 1H NMR (400 MHz, DMSO-d6į-7.83 (5H, m), 13.37 
(1H, s); 13C NMR (101 MHz, CDCl3 į       
)7,5Ȟmax  2944 (br), 2558 (br), 2159 (br), 2031 (w), 1807 (s), 1674 (s), 1489 (s), 1308 (m), 
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1212 (s), 1063 (m), 1027 (m); HRMS (ESI-TOF) m/z [M+H]+ calculated for C9H7N2O4: 
207.0406. Found: 207.0413. 
4-[(N-Methoxy-N-methyl)amide]-N-phenylsydnone: 
To a solution of 4-carboxylic acid-N-phenylsydnone (500 mg, 2.43 mmol) in CH2Cl2 (10 mL) 
at 0 RC was added oxalyl chloride (924 mg, 7.28 mmol) and DMF (3 drops) and the mixture 
stirred for 10 minutes at 0 RC. The reaction was allowed to warm to room temperature and 
stirred for a further 3 hours. Volatiles were then removed in vacuo and the resulting yellow 
solid dissolved in CH2Cl2 (10 mL). Triethylamine (541 mg, 5.35 mmol) and N,O-
dimethylhydroxylamine hydrogen chloride (284 mg, 2.92 mmol) were added at 0 RC and the 
reaction stirred for 14 hours at RT. The reaction was poured into water, extracted with 
CH2Cl2, the combined organic layers were dried over MgSO4 and volatiles removed in vacuo. 
The resulting crude material was purified by flash silica chromatography (gradient 100% 40-
60 petroleum ether to 60% ethyl acetate) affording the title compound as a yellow oil (394 
mg, 65%). 
1H NMR (400 MHz, CDCl3į+V+V-7.61 (4H, m), 7.61-7.69 (1H, 
m); 13C NMR (101 MHz, CDCl3 į        
)7,5Ȟmax  1765 (s), 1651 (m), 1480 (m), 1443 (w), 1269 (w), 1173 (w), 1051 (w), 
990 (w); HRMS (ESI-TOF) m/z [M+H]+ calculated for C11H11N3O4: 250.0822. Found: 
250.0821. 
1-(Phenyl)-3-(trimethylsilyl)-5-[(N-Methoxy-N-methyl)amide]-pyrazole, 5a and 1-(phenyl)-
4-(trimethylsilyl)-5-[(N-Methoxy-N-methyl)amide]-pyrazole, 5b:  
Following general procedure B using 4-[(N-methoxy-N-methyl)amide]-N-phenylsydnone 
(213 mg, 0.855 mmol) and trimethylsilylacetylene (336 mg, 3.42 mmol), an inseparable 
mixture of pyrazole 5a and 5b was isolated as an orange oil (231 mg, 89%, >95:5).  
1H NMR (400 MHz, CDCl3į+V+V+V +V-
7.39 (1H, m), 7.40-7.46 (2H, m), 7.47-7.53 (2H, m); 13C NMR (101 MHz, CDCl3 į -1.0, 
33.6, 61.5, 115.1, 123.8, 127.9, 129.2, 135.3, 140.5, 154.0, 162.4; FTIRȞmax 2954 (w), 1650 
(m), 1599 (m), 1499 (m), 1310 (m), 1113 (m), 977 (w), 836 (s); HRMS (ESI-TOF) m/z 
[M+H]+ calculated for C15H21N3O2Si: 304.1476. Found: 304.1481. 
4-(3-trifluoromethylphenyl)-N-benzylsydnone: 
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Following general procedure A using N-benzylsydnone (500 mg, 2.84 mmol) and 3-
bromotrifluoromethyl benzene (958 mg, 4.26 mmol), the title compound was isolated as a 
colourless solid (342 mg, 38%).  
M.p.: 81-82 qC; 1H NMR (400 MHz, CDCl3 į  + V -725 (2H, m), 7.34-7.45 
(3H, m), 7.50-7.60 (2H, m), 7.60-7.72 (2H, m); 13C NMR (101 MHz, CDCl3į
123.6 (q, J = 272.5 Hz), 125.1 (q, J = 3.5 Hz), 125.4, 126.1 (q, J = 3.5 Hz), 127.6, 129.6, 
129.86, 129.91, 130.9, 131.65 (q, J = 33.0 Hz), 131.68, 167.3; 19F NMR (377 MHz, CDCl3į
-62.9; FTIR Ȟmax 2954 (w), 1732 (s), 1524 (m), 1432 (m), 1360 (m), 1321 (m),  1159 (s), 
1112 (s), 1005 (s), 907 (s), 815 (m); HRMS (ESI-TOF) m/z [M+H]+ calculated for 
C16H12F3N2O2: 321.0845. Found: 321.0848.  
 
1-(Benzyl)-3-(trimethylsilyl)-5-(3-trifluoromethylphenyl)-pyrazole, 7a and 1-(benzyl)-4-
(trimethylsilyl)-5-(3-trifluoromethylphenyl)-pyrazole, 7b:  
Following general procedure B using 4-(3-trifluoromethylphenyl)-N-benzylsydnone (99 mg, 
0.31 mmol) and trimethylsilylacetylene (104 mg, 1.06 mmol), an inseparable mixture of 
pyrazole 7a and 7b was isolated as an orange oil (89 mg, 77%, 95:5).  
1H NMR (400 MHz, CDCl3į+V+V+V+GJ = 6.5 
Hz), 7.20-7.30 (3H, m), 7.40-7.51 (3H, m), 7.60 (1H, d, J = 7.5 Hz); 13C NMR (101 MHz, 
CDCl3į-0.9, 53.7, 113.7, 122.6 (s, q not distinguishable), 125.1 (q, J = 3.5 Hz), 125.8 (q, J 
= 3.5 Hz), 126.8, 127.7, 128.8, 129.2, 131.0 (q, J = 32.5 Hz), 131.9, 132.1, 137.6, 142.5, 
153.0; 19F NMR (377 MHz, CDCl3į-62.3; FTIRȞmax 2958 (w), 1455 (m), 1311 (s), 1248 
(m), 1167 (s), 1125 (s), 1073 (s), 983 (m), 837 (s); HRMS (ESI-TOF) m/z [M+H]+ calculated 
for C20H21F3N2Si: 375.1499. Found: 375.1508.  
1-(Benzyl)- 5-(3-trifluoromethylphenyl)-pyrazole, 8:  
Following general procedure C using a mixture of pyrazoles 7a and 7b (81 mg, 0.22 mmol) 
and TBAF in THF (2.2 mL, 2.2 mmol), pyrazole 8 was isolated as a yellow oil (45 mg, 69%). 
1H NMR (400 MHz, CDCl3 į  + V  + G J = 2.0 Hz), 7.01-7.10 (2H, m), 
7.23-7.34 (3H, m), 7.46-7.57 (3H, m), 7.61-7.68 (2H, m); 13C NMR (101 MHz, CDCl3 į
53.7, 107.2, 123.9 (q, J = 272.5 Hz), 125.5 (q, J = 3.5 Hz), 126.0 (q, J = 3.5 Hz), 126.9, 
127.9, 128.9, 129.3, 131.3 (q, J = 32.5 Hz), 131.6, 132.3, 137.3, 139.4, 142.6; 19F NMR (377 
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MHz, CDCl3į-62.8; FTIRȞmax 2668 (w), 1340 (m), 1321 (s), 1166 (s), 1118 (s), 1072 (s), 
928 (m), 906 (m); HRMS (ESI-TOF) m/z [M+H]+ calculated for C17H13F3N2: 303.1104. 
Found: 303.1107.  
4-(3-Hydroxy-4-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)sydnone:  
Following general procedure A using N-(3,4,5-trimethoxyphenyl)sydnone (500 mg, 1.98 
mmol) and 5-bromo-2-methoxyphenol (604 mg, 2.97 mmol). Flash silica chromatography 
(eluting solvent 10%-30% ethyl acetate in dichloromethane) afforded the title compound as a 
yellow solid (599 mg, 81%).  
M.p.: 237-239 qC (dec.); 1H NMR (400 MHz, DMSO-d6į+V+V
(1H, dd, J = 8.5, 2.0 Hz), 6.88 (1H, d, J = 2.0 Hz), 6.91 (1H, d, J = 8.5 Hz), 7.13 (2H, s), 9.28 
(1H, s);  13C NMR (101 MHz, DMSO-d6 į       
)7,5Ȟmax 3415 (br), 3062 (w), 2947 
(w), 1718 (s), 1605 (m), 1243 (s), 1125 (s), 1014 (s), 949 (m);  HRMS calculated for 
C18H19N2O7 (ES+)(+H+): 375.1192. Found: 375.1192.  
4-(3-[(Tert-butyldimethylsilyl)oxy]-4-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)sydnone:  
To a solution of 4-(3-hydroxy-4-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)sydnone (200 
mg, 0.535 mmol) and TBSCl (161 mg, 1.07 mmol) in DMF
 
(2 mL), under an atmosphere of 
nitrogen, was added DIPEA (138 mg, 1.07 mmol) and the reaction stirred at room 
temperature for 14 hours. Aqueous NH4Cl was added and the mixture extracted with ethyl 
acetate. The organic phase was dried over MgSO4 and the volatiles were removed in vacuo. 
Flash silica chromatography (gradient 100% 40-60 petroleum ether to 40% ethyl acetate) 
afforded the title compound as an orange solid (211 mg, 81%).  
M.p.: 97-98 RC; 1H NMR (400 MHz, CDCl3į+V+V+V
(3H, s),  3.91 (3H, s), 6.67 (1H, d, J = 2.5 Hz), 6.68 (2H, s),  6.82 (1H, d, J = 8.5 Hz), 7.18 
(1H, dd, J = 8.5, 2.5 Hz); 13C NMR (101 MHz, CDCl3į-4.7, 18.4, 25.7, 55.6, 56.6, 61.2, 
102.6, 108.1, 112.2, 117.1, 119.7, 121.6, 130.1, 140.7, 145.1, 151.8, 154.2, 167.1; FTIRȞmax  
2933 (w), 1729 (m), 1606 (m), 1460 (m), 1225 (s), 1125 (s), 1015 (m), 999 (m), 946 (m), 837 
(s); HRMS (ESI-TOF) m/z [M+H]+ calculated for C24H33N2O7Si: 489.2057. Found: 489.2081. 
1-(3,4,5-Trimethoxyphenyl)-3-(trimethylsilyl)-5-(3-[(tert-butyldimethylsilyl)oxy]-4-
methoxyphenyl)-pyrazole, 9a and 1-(3,4,5-trimethoxyphenyl)-4-(trimethylsilyl)-5-(3-[(tert-
butyldimethylsilyl)oxy]-4-methoxyphenyl) -pyrazole, 9b:  
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Following general procedure B using 4-(3-[(tert-butyldimethylsilyl)oxy]-4-methoxyphenyl)-
N-(3,4,5-trimethoxyphenyl)sydnone (150 mg, 0.307 mmol) and trimethylsilylacetylene (121 
mg, 1.23 mmol), an inseparable mixture of pyrazoles 9a and 9b was isolated as a clear oil 
(136 mg, 82%, 95:5).  
1H NMR (400 MHz, CDCl3į01 (6H, s), 0.35 (9H, s), 0.90 (9H, s), 3.70 (6H, s), 3.79 (3H, 
s),  3.81 (3H, s), 6.52 (1H, s),  6.54 (2H, s), 6.68 (1H, d, J = 2.0 Hz), 6.79 (1H, d, J = 8.5 Hz), 
6.87 (1H, dd, J = 8.5, 2.0 Hz); 13C NMR (101 MHz, CDCl3į -4.8, -0.9, 18.4, 25.7, 55.6, 
56.1, 61.0, 103.3, 111.8, 113.4, 121.4, 122.4, 123.6, 136.2, 137.2, 143.0, 144.8, 151.1, 153.2, 
)7,5Ȟmax 2954 (w), 2930 (w), 2857 (w), 1598 (m), 1496 (m), 1463 (m), 1415 (m), 
1229 (s), 1127 (s), 1007 (m), 979 (m) 980 (m), 937 (m); HRMS (ESI-TOF) m/z [M+H]+ 
calculated for C28H43N2O5Si2: 543.2711. Found: 543.2728. 
1-(3,4,5-Trimethoxyphenyl)-5-(3-hydroxy-4-methoxyphenyl)-pyrazole, 10 and 1-(3,4,5-
trimethoxyphenyl)-5-(3-fluoromethoxy-4-methoxyphenyl)-pyrazole, 14: 
Following general procedure C using a mixture of pyrazoles 9a and 9b (131 mg, 0.241 mmol, 
95:5) and TBAF in THF (2.4 mL, 2.4 mmol), pyrazole 10 was isolated as a colourless solid 
(12 mg, 14%) and pyrazole 14 was isolated as a clear oil (21 mg, 22%).  
10: M.p.: 102-103 qC; 1H NMR (400 MHz, CDCl3į+V+V+V
5.99 (1H, br), 6.42 (1H, d, J = 2.0 Hz), 6.53 (2H, s), 6.69 (1H, dd, J = 8.5, 2.0 Hz), 6.76 (1H, 
d, J = 8.5, Hz), 6.87 (1H, d, J = 2.0, Hz), 7.65 (1H, d, J = 2.0 Hz); 13C NMR (101 MHz, 
CDCl3 į            
)7,5Ȟmax  3133 (br), 2933 (w), 2840 (w), 1601 (m), 1499 (s), 
1458 (m), 1420 (m), 1272 (m), 1232 (s), 1118 (s), 1010 (m), 1002 (m), 933 (m); HRMS (ESI-
TOF) m/z [M+H]+ calculated for C19H21N2O5: 357.1445. Found: 357.1446. 
14: 1H NMR (400 MHz, CDCl3į0 (6H, d, J = 1.5 Hz), 3.84 (3H, d, J = 1.5 Hz),  3.88 
(3H, d, J = 1.5 Hz), 5.58 (2H, dd, J = 54.5, 1.5 Hz), 6.48 (1H, t, J = 1.5 Hz),  6.53 (2H, d, J = 
1.5 Hz), 6.88 (1H, dd, J = 8.5, 1.5 Hz), 6.98-7.05 (2H, m), 7.69 (1H, t, J = 1.5 Hz); 13C NMR 
(101 MHz, CDCl3įG J = 220.5 Hz), 103.2, 107.3, 112.1, 118.3, 
123.4, 125.0, 135.8, 137.5, 140.2, 142.3, 145.4, 149.9, 153.3; 19F NMR (377 MHz, CDCl3į
-149.1 (t, J  +])7,5Ȟmax 2933 (w), 2838 (w), 1598 (m), 1505 (s), 1455 (m), 1417 (m), 
1229 (s), 1119 (s), 1002 (m), 972 (m); HRMS (ESI-TOF) m/z [M+H]+ calculated for 
C20H22N2O5F: 389.1513. Found: 389.1499. 
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1-(3,4,5-Trimethoxyphenyl)-5-(3-hydroxy-4-methoxyphenyl)-pyrazole, 10:  
Following general procedure C a mixture of pyrazoles 9a and 9b (100 mg, 0.184 mmol) and 
TBAF in THF (1.8 mL, 1.8 mmol), pyrazole 10 was isolated as a colourless solid (46 mg, 
70%).  
See above for characterisation data. 
4-[N-(2-Hydroxy-1,1-dimethylethyl)amide]-N-phenylsydnone: 
To a solution of 4-carboxylic acid-N-phenylsydnone (825 mg, 4.00 mmol) in CH2Cl2 (40 mL) 
at 0 RC was added oxalyl chloride (1.52 g, 12.0 mmol) and DMF (3 drops) and the mixture 
stirred for 10 minutes at 0 RC. The reaction was allowed to warm to room temperature and 
stirred for a further 3 hours. Volatiles were then removed in vacuo and the resulting yellow 
solid dissolved in CH2Cl2 (40 mL). Triethylamine (486 mg, 4.80 mmol) and 2-amino-2-
methylpropanol (428 mg, 4.80 mmol) were added at 0 RC and the reaction stirred for 14 hours 
at RT. The reaction was poured into water, extracted with CH2Cl2, the combined organic 
layers were dried over MgSO4 and volatiles removed in vacuo. The resulting crude material 
was purified by flash silica chromatography (eluting solvent 100% ethyl acetate) affording 
the title compound as a yellow solid (975 mg, 88%). The product could be further purified by 
recrystallisation from CH2Cl2/petrol.  
 M.p.: 184 qC; 1H NMR (400 MHz, CDCl3į+V+V+, br), 7.42 ± 
7.86 (5H, m); 13C NMR (101 MHz, CDCl3į
)7,5Ȟmax  3318 (br), 1751 (s), 1675 (s), 1494 (w), 1303 (w), 1059 (w); 
HRMS (ESI-TOF) m/z [M+H]+ calculated for C13H16N3O4: 278.1141. Found: 278.1148. 
4-(4,4-Dimethyl-2-oxazoline)-N-phenylsydnone: 
Triethylamine (5.28 g, 52.2 mmol) and carbon tetrachloride (12.3 g, 80.0 mmol) were added 
respectively to a suspension of 4-[N-(2-hydroxy-1,1-dimethylethyl)amide]-N-phenylsydnone 
(964 mg, 3.48 mmol) and triphenylphosphine (3.65 g, 13.9 mmol) in acetonitrile (17 mL) at 
ambient temperature. The reaction was allowed to stir for 2 h before being diluted with ethyl 
acetate and washed with aqueous sodium hydrogen carbonate.
 
The aqueous layer was 
extracted with ethyl acetate, the organics combined, dried over magnesium sulfate
 
and the 
solvent removed in vacuo. The resulting residue was purified by flash silica chromatography 
(gradient 0 ± 60% ethyl acetate in 40/60 petroleum ether) affording the title compound as a 
yellow solid (475 mg, 53%).  
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M.p.: 131-133 qC; 1H NMR (400 MHz, CDCl3į+V+V± 7.71 (5H, 
m); 13C NMR (101 MHz, CDCl3į
165.5; )7,5Ȟmax  1785 (s), 1754 (m), 1658 (m), 1485 (m); HRMS (ESI-TOF) m/z [M+H]+ 
calculated for C13H14N3O3: 260.1035. Found: 260.1039. 
1-(Phenyl)-3-(trimethylsilyl)-5-(4,4-dimethyl-2-oxazoline)-pyrazole, 11a and 1-(phenyl)-4-
(trimethylsilyl)-5-(4,4-dimethyl-2-oxazoline)-pyrazole, 11b:  
Following general procedure B using 4-(4,4-dimethyl-2-oxazoline)-N-phenylsydnone (98 mg, 
0.38 mmol) and trimethylsilylacetylene (149 mg, 1.51 mmol), an inseparable mixture of 
pyrazole 11a and 11b was isolated as an orange oil (103 mg, 87%, 95:5). 
1H NMR (400 MHz, CDCl3į+V+V+V7.08 (1H, s), 7.34-7.51 
(5H, m); 13C NMR (101 MHz, CDCl3į -1.0, 28.1, 67.8, 79.3, 118.0, 125.3, 128.1, 128.6, 
131.6, 140.6, 154.2, 155.3; FTIRȞmax 2961 (w), 2896 (w), 1667.0 (m), 1599 (m), 1500 (m), 
1312 (m), 1248 (m), 1192 (m), 1068 (s), 1006 (m), 979 (m), 837 (s); HRMS (ESI-TOF) m/z 
[M+H]+ calculated for C17H23N3OSi: 314.1683. Found: 314.1696.  
1-(Phenyl)-5-(4,4-dimethyl-2-oxazoline)-pyrazole, 12 and 3-(phenylamino)-3-(4,4-dimethyl-
2-oxazoline)-2-propenenitrile (E+Z), 13:  
Following general procedure C using a mixture of pyrazoles 11a and 11b (102 mg, 0.325 
mmol) and TBAF in THF (3.3 mL, 3.3 mmol), pyrazole 12 was isolated as an orange oil (37 
mg, 47%) and nitrile 13 was isolated as an orange oil (18 mg, 23%, E:Z ~1:1). 
`12: 1H NMR (400 MHz, CDCl3į+V+V+GJ = 2.0 Hz), 7.35-
7.48 (5H, m), 7.68 (1H, d, J = 2.0 Hz); 13C NMR (101 MHz, CDCl3 į   
111.1, 125.1, 128.2, 128.6, 129.9, 131.5, 140.2, 154.7; FTIRȞmax 2965 (w), 1662 (m), 1588 
(s), 1499 (s), 1394 (m), 1355 (m), 1289 (m), 1084 (m), 999 (s), 955 (s); HRMS (ESI-TOF) 
m/z [M+H]+ calculated for C14H16N3O: 242.1288. Found: 242.1290.  
13 (1:1 mixture of E/Z isomers): 1H NMR (400 MHz, CDCl3į+V+V
4.14 (1H, s), 4.29 (1H, s), 4.92 (0.5H, d, J = 1.5 Hz), 4.95 (0.5H, d, J = 1.5 Hz), 7.14 (0.5H, 
br), 7.15-7.25 (3.5H, m), 7.39 (1H, t, J = 7.5 Hz); 13C NMR (101 MHz, CDCl3į
68.3, 68.6, 69.0, 80.7, 81.2, 116.8, 118.7, 123.7, 125.0, 126.0, 126.5, 129.0, 129.9, 137.5, 
137.9, 142.8, 144.3, 158.9, 159.2; FTIRȞmax 2974 (w), 2200 (w), 1681 (m), 1587 (s), 1495 
(m), 1448 (m), 1366 (m), 1300 (m), 962 (m); HRMS (ESI-TOF) m/z [M+H]+ calculated for 
C14H16N3O: 242.1288. Found: 242.1288.  
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1-(3,4,5-Trimethoxyphenyl)-5-(3-hydroxy-4-methoxyphenyl)-pyrazole, 14:  
A flask was charged with pyrazole 10 (51 mg, 0.14 mmol), CH2Cl2 (0.5 mL) and TBAF in 
THF (1 M, 1.5 mL, 1.5 mmol) and the reaction heated at reflux for 14 h. The reaction was 
allowed to cool to ambient temperature and poured into aq. NaHCO3, extracted with ethyl 
acetate and volatiles removed in vacuo. The resulting crude material was purified by flash 
silica chromatography (gradient 100% petroleum ether ± 60% ethyl acetate in petroleum 
ether) affording 14 as a colourless oil (27 mg, 49%) and recovered pyrazole 10 (13 mg, 25%).  
See above for characterisation data. 
1-Bromo-4-fluoromethoxybenzene, 15 DQG ¶-[methylenebis(oxy)]bis[4-bromobenzene] 
16:14 
A flask was charged with 4-bromophenol (100 mg, 0.585 mmol), CH2Cl2 (0.5 mL) and TBAF 
in THF (1 M, 6 mL, 6 mmol) and the reaction heated at reflux for 14 h. The reaction was 
allowed to cool to ambient temperature and poured into aq. NaHCO3, extracted with ethyl 
acetate and volatiles removed in vacuo. The resulting crude material was purified by flash 
silica chromatography (gradient 100% petroleum ether ± 10% ethyl acetate in petroleum 
ether) affording a mixture of 15 and 16 as a colourless oil (20 mg, 17%, 85:15). The mixture 
was characterised by 1H and 19F NMR only.  
1H NMR (400 MHz, CDCl3į+GJ = 54.5 Hz), 6.91-7.04 (2H, m), 7.38-7.48 (2H, 
m); 19F NMR (128 MHz, CDCl3į-149.1 (t, J = 54.5 Hz). 
3-Fluoromethoxy-4-methoxybenzaldehydebenzene, 17:  
A flask was charged with 3-hydroxy-4-methoxybenzaldehyde (50 mg, 0.33 mmol), CH2Cl2 
(0.5 mL) and TBAF in THF (1 M, 3.3 mL, 3.3 mmol) and the reaction heated at reflux for 14 
h. The reaction was allowed to cool to ambient temperature and poured into aq. NaHCO3, 
extracted with ethyl acetate and volatiles removed in vacuo. The resulting crude material was 
purified by flash silica chromatography (gradient 100% petroleum ether ± 40% ethyl acetate 
in petroleum ether) affording 17 as a colourless solid (25 mg, 41%).  
M.p.: 59-61 qC; 1H NMR (400 MHz, CDCl3į+V+GJ = 54.0 Hz), 7.05 
(1H, d, J = 8.5 Hz), 7.63 (1H, d, J = 8.5, 2.0 Hz), 7.66-7.67 (1H, m), 9.86 (1H, s); 13C NMR 
(101 MHz, CDCl3įGJ = 221.0 Hz), 111.8, 116.4, 128.5, 130.2, 146.3 (d, J = 
2.5 Hz), 155.1, 190.5; 19F NMR (128 MHz, CDCl3 į -149.8 (t, J    +] )7,5 Ȟmax  
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1686 (s), 1601 (m), 1587 (m), 1508 (s), 1439 (s), 1404 (m), 1262 (s), 1228 (s), 1173 (m), 
1135 (s), 1079 (m), 1016 (s), 943 (s); HRMS (ESI-TOF) m/z [M+H]+ calculated for C9H9FO3: 
184.0530. Found: 184.0526.  
A flask was charged with 3-hydroxy-4-methoxybenzaldehyde (50 mg, 0.33 mmol), CH2Cl2 
(0.5 mL) THF (3.3 mL) and the reaction heated at reflux for 14 h. The reaction was allowed 
to cool to ambient temperature and volatiles removed in vacuo, resulting in the recovery of 
starting material. 
3-(1-Fluoro-1,1-dideuteromethoxy)-4-methoxybenzaldehydebenzene, d-17:  
A flask was charged with 3-hydroxy-4-methoxybenzaldehyde (50 mg, 0.33 mmol), CD2Cl2 
(0.5 mL) and TBAF in THF (1 M, 3.3 mL, 3.3 mmol) and the reaction heated at reflux for 14 
h. The reaction was allowed to cool to ambient temperature and poured into aq. NaHCO3, 
extracted with ethyl acetate and volatiles removed in vacuo. The resulting crude material was 
purified by flash silica chromatography (gradient 100% petroleum ether ± 40% ethyl acetate 
in petroleum ether) affording d-17 as a colourless solid (19 mg, 31%).  
M.p.: 57-59 qC; 1H NMR (400 MHz, CDCl3į+V+GJ = 8.5 Hz), 7.64 
(2H, m), 9.86 (1H, s); 13C NMR (101 MHz, CDCl3 į  -102.1 (m), 111.8, 116.3, 
128.5, 130.2, 146.3, 155.1, 190.5; 19F NMR (128 MHz, CDCl3į-151.1- -151.2 (m); FTIR: 
Ȟmax  1690 (s), 1603 (m), 1587 (m), 1508 (s), 1435 (s), 1266 (s), 1164 (m), 1129 (s), 1016 (s), 
916 (s); HRMS (ESI-TOF) m/z [M+H]+ calculated for C9H7D2FO3: 187.0734. Found: 
187.0734. 
1-(Phenyl)-3-(trimethylsilyl)-4-(pinacolatoborolane)-5-(4-tolyl)-pyrazole, 18:15  
Following general procedure D using 4-(4-tolyl)-N-phenylsydnone (200 mg, 0.793 mmol) 
and 4,4,5,5-tetramethyl-2-[2-(trimethylsilyl)ethynyl]-1,3,2-dioxaborolane (356 mg, 1.59 
mmol), pyrazole 18 was isolated as a tan solid (187 mg, 74%).  
1H NMR (400 MHz, CDCl3į+V+V+V+GJ = 8.0 
Hz), 7.11 (2H, d, J = 8.0 Hz), 7.19-7.28 (5H, m); 13C NMR (101 MHz, CDCl3į-0.4, 21.5, 
25.0, 83.2, 114.1, 125.5, 127.0, 128.4, 128.7, 130.6, 137.8, 140.3, 150.0, 159.6. 
1-(Phenyl)-3-(trimethylsilyl)-4-(4-methoxyphenyl)-5-(4-tolyl)-pyrazole, 19:  
Following general procedure E using pyrazole 18 (200 mg, 0.462 mmol) and 4-bromoanisole 
(130 mg, 0.694 mmol), pyrazole 19 was isolated as a yellow solid (172 mg, 90%).  
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1H NMR (400 MHz, CDCl3į+V+V+V), 6.82 (2H, d, J = 9.0 
Hz), 6.89 (2H, d, J = 8.0 Hz), 6.97 (2H, d, J = 8.0 Hz), 7.10 (2H, d, J = 9.0 Hz), 7.21-7.34 
(5H, m); 13C NMR (101 MHz, CDCl3į-0.3, 21.4, 55.2, 110.7, 113.4, 114.3, 119.5, 120.4, 
125.2, 127.0, 128.8, 129.0, 130.2, 131.8, 137.5, 140.6, 152.6, 158.5; )7,5Ȟmax  3050 (w), 
2955 (w), 1598 (m), 1520 (m), 1492 (m), 1449 (s), 1325 (m), 1243 (s), 1037 (m), 990 (m); 
HRMS (ESI-TOF) m/z [M+H]+ calculated for C26H29N2OSi: 413.2044. Found: 413.2042. 
4-(2-Pyridyl)-N-phenylsydnone:16  
Following general procedure A using N-phenylsydnone (1.50 g, 9.25 mmol) and 2-
bromopyridine (2.19 g, 13.9 mmol), the title compound was isolated as colourless crystals 
(2.19 g, 99%). 
M.p.: 111-112 qC (lit.16 142-143 RC); 1H NMR (400 MHz, CDCl3į+GGGJ = 7.5, 
5.0, 1.0 Hz), 7.46-7.58 (4H, m), 7.60-7.66 (1H, m), 7.74 (1H, td, J = 8.0, 2.0 Hz), 8.09 (1H, 
dt, J = 8.0, 1.0 Hz), 8.23 (1H, ddd, J = 5.0, 2.0, 1.0 Hz); 13C NMR (101 MHz, CDCl3 į
107.1, 121.8, 122.7, 125.1, 129.3, 131.6, 136.0, 136.8, 144.9, 149.1, 167.1.  
 1-(Phenyl)-3-(trimethylsilyl)-4-(pinacolatoborolane)-5-(2-pyridyl)-pyrazole, 21:  
Following general procedure D using 4-(2-pyridyl)-N-phenylsydnone (200 mg, 0.836 mmol) 
and 4,4,5,5-tetramethyl-2-[2-(trimethylsilyl)ethynyl]-1,3,2-dioxaborolane (375 mg, 1.67 
mmol), pyrazole 21 was isolated as a yellow solid (184 mg, 52%).  
1H NMR (400 MHz, CDCl3į+V+V), 7.16-7.28 (7H, m), 7.57 (1H, td, J 
= 7.5, 2.0 Hz), 8.56 (1H, ddd, J = 5.0, 2.0, 1.0 Hz); 13C NMR (101 MHz, CDCl3į-0.5, 25.1, 
83.3, 115.4, 122.7, 125.2, 125.6, 127.2, 128.8, 135.5, 140.3, 149.1, 151.1, 159.5; )7,5Ȟmax  
2971 (w), 1593 (m), 1496 (m), 1410 (m), 1312 (m), 1140 (m), 1043 (m); HRMS (ESI-TOF) 
m/z [M+H]+ calculated for C23H3111BN3O2Si: 419.2309. Found: 419.2311. 
 1-(Phenyl)-3-(trimethylsilyl)-4-(4-methoxyphenyl)-5-(2-pyridyl)-pyrazole, 22:  
Following general procedure E using pyrazole 21 (158 mg, 0.377 mmol) and 4-bromoanisole 
(106 mg, 0.565 mmol), pyrazole 22 was isolated as a yellow solid (90 mg, 60%).  
1H NMR (400 MHz, CDCl3į+V+V+GJ = 9.0 Hz) 7.05 (1H, 
dt, J = 8.0, 1.0 Hz), 7.07-7.15 (3H, m), 7.20-7.25 (1H, m), 7.26-7.30 (4H, m), 7.50 (1H, td, J 
= 7.5, 2.0 Hz), 8.45 (1H, ddd, J = 5.0, 2.0, 1.0 Hz); 13C NMR (101 MHz, CDCl3į-0.3, 55.2, 
113.4, 122.4, 124.8, 125.7, 126.6, 127.0, 128.7, 130.7, 131.7, 136.0, 139.3, 140.6, 149.7, 
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150.4, 152.6, 158.7; FTIRȞmax  3047 (w), 2965 (w), 2836 (w), 1584 (m), 1500 (m), 1246 (s), 
1175 (m), 1034 (m); HRMS (ESI-TOF) m/z [M+H]+ calculated for C24H26N3OSi: 400.1840. 
Found: 400.1848 
 1-(Phenyl)-4-(4-methoxyphenyl)-5-(2-pyridyl)-pyrazole, 23:  
Following general procedure C using pyrazole 22 (83 mg, 0.21 mmol) and TBAF in THF (2.1 
mL, 2.1 mmol), pyrazole 23 was isolated as a yellow crystalline solid (30 mg, 44%).  
M.p.: 138-139 qC; 1H NMR (400 MHz, CDCl3į+V+GJ = 7.5 Hz), 6.75 
(1H, s), 6.90 (2H, d, J = 9.0 Hz), 7.06-7.11 (2H, m), 7.33 (1H, ddd, J = 6.0, 5.0, 2.5 Hz), 7.45 
(2H, d, J = 9.0 Hz), 7.67-7.76 (2H, m), 8.72 (1H, dt, J = 5.0, 1.5 Hz ); 13C NMR (101 MHz, 
CDCl3 į  91.4, 114.8, 120.7, 121.2, 123.2, 124.8, 125.3, 125.6, 129.0, 130.1, 136.9, 
140.4, 150.0, 151.3, 152.5, 159.5; FTIRȞmax  2925 (w), 1580 (m), 1509 (s), 1377 (m), 1282 
(m), 1109 (s), 944 (s),; HRMS (ESI-TOF) m/z [M+H]+ calculated for C21H17N3O: 328.1444. 
Found: 328.1449.  
4-(2-Thiophenyl)-N-phenylsydnone:  
Following general procedure A using N-phenylsydnone (500 mg, 3.08 mmol) and 2-
chlorothiophene (549 mg, 4.63 mmol), the title compound was isolated as a yellow solid (636 
mg, 85%). 
M.p.: 168-170 qC; 1H NMR (400 MHz, CDCl3į+GGJ = 5.0, 4.0 Hz), 7.24 (1H, 
dd, J = 5.0, 1.0 Hz), 7.29 (1H, dd, J = 4.0, 1.0 Hz), 7.55-7.60 (2H, m), 7.64-7.70 (2H, m), 
7.73-7.80 (1H, m); 13C NMR (101 MHz, CDCl3į
130.4, 132.8, 133.9, 165.9; )7,5 Ȟmax  3108 (w), 3077 (w), 1725 (s), 1703 (m), 1250 (s), 
1046 (m); HRMS (ESI-TOF) m/z [M+H]+ calculated for C12H9N2O2S: 245.0385. Found: 
245.0376.  
1-(Phenyl)-3-(trimethylsilyl)-4-(pinacolatoborolane)-5-(2-thiophenyl)-pyrazole, 24a and 1-
(Phenyl)-3-(pinacolatoborolane)-4-(trimethylsilyl)-5-(2-thiophenyl)-pyrazole, 24b:  
Following general procedure D using 4-(2-thiophenyl)-N-phenylsydnone (200 mg, 0.819 
mmol) and 4,4,5,5-tetramethyl-2-[2-(trimethylsilyl)ethynyl]-1,3,2-dioxaborolane (367 mg, 
1.64 mmol), pyrazole 24a isolated as a yellow solid (221 mg, 64%) and pyrazole 24b was 
isolated as a brown oil (21 mg, 6%).  
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24a: 1H NMR (400 MHz, CDCl3įH, s), 1.27 (12H, s), 6.95 (1H, dd, J = 5.0, 3.5 Hz), 
7.00 (1H, dd, J = 3.5, 1.0 Hz), 7.25-7.33 (6H, m); 13C NMR (101 MHz, CDCl3į-0.4, 25.0, 
83.4, 125.7, 126.5, 127.3, 127.6, 128.8, 129.9, 131.5, 140.1, 143.0, 159.8; )7,5Ȟmax  2979 
(w), 1596 (w), 1496 (s), 1440 (m), 1317 (m), 1241 (s), 1137 (s), 1020 (s); HRMS (ESI-TOF) 
m/z [M+H]+ calculated for C22H3011BN2O2SSi: 424.1921. Found: 424.1923.  
24b: 1H NMR (400 MHz, CDCl3į+V+V), 6.91 (1H, dd, J = 3.5, 1.0 
Hz), 6.95 (1H, dd, J = 5.0, 3.5 Hz), 7.22-7.33 (6H, m); 13C NMR (101 MHz, CDCl3į-0.5, 
25.1, 84.2, 125.1, 126.0, 126.7, 127.7, 127.9, 128.5, 130.8, 132.5, 139.9, 141.1; )7,5Ȟmax  
2976 (w), 1598 (w), 1456 (m), 1245 (s), 1221 (m), 1137 (s), 1030 (m); HRMS (ESI-TOF) m/z 
[M+H]+ calculated for C28H3011BN2O2SSi: 424.1921. Found: 424.1918. 
1-(Phenyl)-3-(trimethylsilyl)-4-(4-tolyl)-5-(2-thiophenyl)-pyrazole, 25:  
Following general procedure E using pyrazole 24a (202 mg, 0.476 mmol) and 4-
bromotoluene (122 mg, 0.714 mmol), pyrazole 25 was isolated as a yellow solid (131 mg, 
71%). 
1H NMR (400 MHz, CDCl3į+V+V+GGJ = 3.5, 1.0 Hz), 6.84 
(1H, dd, J = 5.0, 3.5 Hz), 7.10-7.17 (4H, m), 7.20 (1H, dd, J = 5.0, 1.0 Hz), 7.29-7.43 (5H, 
m); 13C NMR (101 MHz, CDCl3 į -0.4, 21.4, 110.7, 119.3, 120.3, 125.6, 126.8, 127.1, 
127.6, 128.7, 128.8, 128.9, 130.6, 134.0, 136.7, 140.2, 152.5; )7,5Ȟmax  3067 (w), 2955 (w), 
1595 (w), 1498 (s), 1310 (m), 991 (m); HRMS (ESI-TOF) m/z [M+H]+ calculated for 
C23H25N2SSi: 389.1502. Found: 389.1500.  
1-(Phenyl)4-(4-tolyl)-5-(2-thiophenyl)-pyrazole, 26:  
Following general procedure C using pyrazole 25 (129 mg, 0.332 mmol) and TBAF in THF 
(3.3 mL, 3.3 mmol), pyrazole 26 was isolated as an orange crystalline solid (20 mg, 19%).  
M.p.: 150-151 qC; 1H NMR (400 MHz, CDCl3į+V+V+GJ = 
7.5 Hz), 6.95-7.00 (1H, m), 7.09 (1H, dd, J = 5.0, 3.5 Hz), 7.12-7.23 (4H, m), 7.39 (2H, d, J 
= 7.5 Hz), 7.44 (1H, dd, J = 5.0, 1.0 Hz), 7.70 (1H, dd, J = 3.5, 1.0 Hz); 13C NMR (101 MHz, 
CDCl3 į   102.5, 121.5, 123.3, 127.7, 128.4, 129.2, 129.9, 130.2, 130.5, 132.0, 
136.0, 138.3, 141.2, 146.4; FTIRȞmax  2950 (w), 1575 (s), 1509 (s), 1493 (s), 1421 (s), 1234 
(m), 1109 (m), 947 (m); HRMS (ESI-TOF) m/z [M+H]+ calculated for C20H17N2S: 317.1107. 
Found: 317.1106.  
Page 23 
 
1-(Methyl)-3-(trimethylsilyl)-4-(pinacolatoborolane)-5-(4-tolyl)-pyrazole, 27:  
Following general procedure D using 4-(4-tolyl)-N-methylsydnone (150 mg, 0.789 mmol) 
and 4,4,5,5-tetramethyl-2-[2-(trimethylsilyl)ethynyl]-1,3,2-dioxaborolane (354 mg, 1.58 
mmol), pyrazole 27 was isolated as a yellow solid (162 mg, 55%).  
1H NMR (400 MHz, CDCl3į+V+V+V+V), 7.20 
(2H, d, J = 8.0 Hz), 7.25 (2H, d, J = 8.0 Hz); 13C NMR (101 MHz, CDCl3į-0.4, 21.5, 24.9, 
37.1, 82.9, 112.6 (br), 128.5, 130.2, 138.1, 151.1, 158.7; )7,5 Ȟmax  2976 (w), 2897 (w), 
1497 (s), 1301 (s), 1239 (s), 1141 (s), 1039 (s); HRMS (ESI-TOF) m/z [M+H]+ calculated for 
C20H3211BN2O2Si: 370.2357. Found: 370.2358. 
1-(Methyl)-3-(trimethylsilyl)-4-(4-tolyl)-5-(3-trifluoromethylphenyl)-pyrazole, 28:  
Following general procedure E using pyrazole 27 (162 mg, 0.437 mmol) and 3-
trifluoromethylbromobenzene (147 mg, 0.656 mmol), pyrazole 28 was isolated as a yellow 
solid (93 mg, 55%) 
1H NMR (400 MHz, CDCl3į+V), 2.35 (3H, s), 3.86 (3H, s), 7.07 (2H, d, J = 8.0 
Hz), 7.15 (2H, d, J = 8.0 Hz), 7.24 (1H, d, J = 8.0 Hz), 7.31 (1H, t, J = 7.5 Hz), 7.46 (1H, d, J 
= 8.0 Hz), 7.50 (1H, s); 13C NMR (101 MHz, CDCl3į-0.2, 21.4, 37.5, 110.7, 119.9 (d, J = 
99.5 Hz), 123.2 (dd, J = 7.5, 3.5 Hz), 124.3 (q, J = 272.5 Hz), 126.9, 127.2-127.5 (m), 129.7 
(d, J = 52.5 Hz), 130.24 (q, J = 32.0 Hz), 133.6, 136.2, 138.5, 141.6, 150.5; 19F NMR (377 
MHz, CDCl3) į-62.)7,5Ȟmax  2956 (w), 1733 (m), 1580 (m), 1510 (m), 1325 (m), 1309 
(m), 1157 (s), 1117 (s), 1014 (m); HRMS (ESI-TOF) m/z [M+H]+ calculated for 
C21H24F3N2Si: 389.1655. Found: 389.1652.  
1-(Methyl)-4-(3,trifluoromethylphenyl)-5-(4-tolyl)-pyrazole, 29:  
Following general procedure E using pyrazole 28 (93 mg, 0.24 mmol) and TBAF in THF (2.4 
mL, 2.4 mmol), pyrazole 29 was isolated as a colourless solid (51 mg, 67%).  
M.p.: 72 qC; 1H NMR (400 MHz, CDCl3į+V+V), 7.18 (2H, d, J = 8.0 
Hz), 7.24-7.30 (4H, m), 7.35-7.40 (1H, m), 7.45 (1H, s), 7.76 (1H, s); 13C NMR (101 MHz, 
CDCl3įG J = 3.5 Hz), 124.0 (d, J = 3.5 Hz), 124.2 (q, J = 272.0 
Hz), 127.0, 128.9, 129.9, 130.0, 130.4, 130.9 (q, J = 32.0 Hz), 134.2, 137.5, 139.3, 140.6; 19F 
NMR (377 MHz, CDCl3į-)7,5Ȟmax  2923 (w), 1520 (m), 1364 (m), 1314 (s), 1156 
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(s), 1119 (s), 991 (m), 905 (m); HRMS (ESI-TOF) m/z [M+H]+ calculated for C18H16F3N2: 
317.1260. Found: 317.1258.  
4-(4-Methoxyphenyl)-N-(4-ethoxyphenyl)sydnone:  
Following general procedure A using N-(4-ethoxyphenyl)sydnone (500 mg, 2.42 mmol) and 
4-bromoanisole (680 mg, 3.64 mmol), the title compound was isolated as a tan solid (566 mg, 
75%). 
M.p.: 169 qC; 1H NMR (400 MHz, CDCl3į+WJ = 7.0 Hz), 3.78 (3H, s), 4.10 (2H, 
q, J = 7.0 Hz), 6.82 (2H, d, J = 9.0 Hz), 7.00 (2H, d, J = 9.0 Hz), 7.24 (2H, d, J = 9.0 Hz), 
7.37 (2H, d, J = 9.0 Hz); 13C NMR (101 MHz, CDCl3į
117.1, 126.3, 127.3, 129.0, 159.8, 161.5, 167.4; )7,5Ȟmax  2980 (w), 2936 (w), 1737 (s), 
1608 (m), 1533 (m), 1516 (m), 1251 (s), 1185 (m), 1013 (m), 998 (m), 971 (m); HRMS (ESI-
TOF) m/z [M+H]+ calculated for C17H17N2O4: 313.1188. Found: 313.1177. 
1-(4-Ethoxyphenyl)-3-(trimethylsilyl)-4-(pinacolatoborolane)-5-(4-methoxyphenyl)-pyrazole, 
30a and 1-(4-ethoxyphenyl)-3-(pinacolatoborolane)-4-(trimethylsilyl)-5-(4-methoxyphenyl)-
pyrazole, 30b:  
Following general procedure D using 4-(4-methoxyphenyl)-N-(4-ethoxyphenyl)sydnone (177 
mg, 0.567 mmol) and 4,4,5,5-tetramethyl-2-[2-(trimethylsilyl)ethynyl]-1,3,2-dioxaborolane 
(254 mg, 1.13 mmol), pyrazole 30a was isolated as a brown solid (179 mg, 64%) and 
pyrazole 30b was isolated as a brown oil (28 mg, 10%, ~85% purity).  
30a:1H NMR (400 MHz, CDCl3į+V+V+WJ = 7.0 Hz), 3.80 
(3H, s), 3.99 (2H, q, J = 7.0 Hz), 6.74-6.81 (4H, m), 7.09-7.17 (4H, m); 13C NMR (101 MHz, 
CDCl3į-0.3, 14.9, 25.0, 55.3, 63.7, 83.1, 113.0, 114.4, 123.8, 126.8, 132.0, 133.5, 149.8, 
157.9, 159.3, 159.4; )7,5Ȟmax  2977 (w), 2898 (w), 1615 (w), 1543 (w), 1515 (s), 1410 (m), 
1238 (s), 1139 (s), 1042 (s), 1033 (s); HRMS (ESI-TOF) m/z [M+H]+ calculated for 
C27H3811BN2O4Si: 492.2725. Found: 492.2722.  
30b:1H NMR (400 MHz, CDCl3į+V-1.40 (15H, m), 3.78 (3H, s), 3.95 (2H, 
q, J = 7.0 Hz), 6.69 (2H, d, J = 9.0 Hz), 6.78 (2H, d, J = 8.5 Hz), 7.03 (2H, d, J = 8.5 Hz), 
7.09 (2H, d, J = 9.0 Hz). 
1-(4-Ethoxyphenyl)-3-(trimethylsilyl)-4-(2-methoxyphenyl)-5-(4-methoxyphenyl)-pyrazole, 
31:  
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Following general procedure E using pyrazole 30a (150 mg, 0.305 mmol) and 2-
bromoanisole (85 mg, 0.47 mmol), pyrazole 31 was isolated as a yellow oil (132 mg, 92%).  
1H NMR (400 MHz, CDCl3į+V), 1.43 (3H, t, J = 7.0 Hz), 3.62 (3H, s), 3.74 (3H, 
s), 4.03 (2H, q, J = 7.0 Hz), 6.68 (2H, d, J = 9.0 Hz), 6.81-6.86 (3H, m), 6.89 (1H, dd, J = 
7.5, 1.0 Hz), 6.94 (2H, d, J = 9.0 Hz), 6.89 (1H, dd, J = 7.5, 1.5 Hz), 7.24-7.29 (3H, m); 13C 
NMR (101 MHz, CDCl3 į -0.6, 14.9, 55.1, 55.3, 63.7, 110.6, 113.5, 114.5, 120.1, 123.4, 
124.1, 125.1, 126.6, 128.6, 130.0, 131.0, 133.0, 133.8, 140.4, 152.3, 157.8, 158.8; )7,5Ȟmax  
2950 (w), 1518 (m), 1477 (m), 1314 (s), 1243 (m), 1156 (s), 1118 (s), 991 (m); HRMS (ESI-
TOF) m/z [M+H]+ calculated for C28H33N2O3Si: 473.2255. Found: 473.2260.  
1-(4-Ethoxyphenyl)-3-4-(2-methoxyphenyl)-5-(4-methoxyphenyl)-pyrazole, 32:  
Following general procedure E using pyrazole 31 (106 mg, 0.224 mmol) and TBAF in THF 
(2.2 mL, 2.2 mmol), pyrazole 32 was isolated as a colourless solid (61 mg, 68%). Note: 
product was contaminated with significant amounts of protodeboronated product from the 
previous steps. 
1H NMR (400 MHz, CDCl3į+WJ = 6.0 Hz), 3.76 (3H, s), 3.89 (3H, s), 4.01 (2H, 
q, J = 6.0 Hz), 6.74 (2H, d, J = 9.0 Hz), 6.79-6.84 (2H, m), 6.95-7.00 (4H, m), 7.13-7.20 (2H, 
m), 7.88 (1H, s), 7.90 (2H, d, J = 9.0 Hz); 13C NMR (101 MHz, CDCl3į
55.4, 55.7, 55.9, 63.8, 63.8, 64.2, 206.8, 111.1, 112.5, 113.8, 114.0, 114.2 114.5, 114.7, 
115.8, 116.5, 117.8, 120.6, 121.6, 122.2, 123.3, 124.2, 126.1, 126.8, 128.1, 130.1, 130.8, 
131.4, 131.9, 133.5, 136.4, 139.9, 140.0, 140.1, 142.9, 156.9, 157.9, 159.2, 159.5, 160.5, 
164.2; )7,5 Ȟmax  2980 (w), 2935 (w), 2837 (w), 1597 (s), 1512 (s), 1244 (m), 1168 (m), 
1025 (m); HRMS (ESI-TOF) m/z [M+H]+ calculated for C25H25N2O3: 317.1260. Found: 
317.1258.  
1-(Phenyl)-3-(n-hexyl)-pyrazole, 33a and 1-(phenyl)-4-(n-hexyl)pyrazole, 33b:  
Following general procedure B using N-phenylsydnone (200 mg, 1.23 mmol) and 1-octyne 
(544 mg, 4.93 mmol), an inseparable mixture of pyrazole 33a and 33b was isolated as a 
yellow oil (182 mg, 65%, 9:1).  
1H NMR (400 MHz, CDCl3 į -0.94 (3H, m), 1.26-1.46 (6H, m), 1.64-1.76 (2H, m), 
2.66-2.78 (2H, m), 6.26 (1H, d, d, J = 2.5 Hz), 7.20-7.29 (1H, m), 7.37-7.48 (2H, m), 7.62-
7.69 (2H, m), 7.82 (1H, d, J = 2.5 Hz); 13C NMR (101 MHz, CDCl3) 14.2, 22.8, 28.6, 29.3, 
29.8, 31.8, 106.6, 119.1, 126.0, 127.4, 129.5, 140.4, 155.6; FTIRȞmax 2925 (m), 2854 (m), 
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1600 (s), 1530 (s), 1503 (s), 1457 (m), 1389 (s), 1324 (m), 1224 (m), 1042 (s), 946 (m); 
HRMS (ESI-TOF) m/z [M+H]+ calculated for C15H21N2: 229.1699. Found: 229.1700. 
1-(Phenyl)-3-(n-hexyl)-4-vinylpyrazole, 34:  
Following general procedure F using pyrazoles 33a and 33b (182 mg, 0.797 mmol), NBS 
(142 mg, 0.797 mmol), vinyllboronic acid pinacol ester (184 mg, 1.20 mmol), XPhosPdG2 
(63 mg, 0.08 mmol) and Na2CO3 (169 mg, 1.59 mmol) for 17 hours, pyrazole 34 was isolated 
as an orange oil (146 mg, 72%).  
1H NMR (400 MHz, CDCl3į-0.95 (3H, m),  1.25-1.48 (6H, m),  1.65-1.76 (2H, m),  
2.68-2.79 (2H, m), 5.36 (1H, dd, J = 11.0, 1.5 Hz), 5.47 (1H, dd, J = 17.5, 1.5 Hz), 6.57 (1H, 
dd, J = 17.5, 11.0 Hz), 7.20-7.28 (1H, m), 7.39-7.58 (2H, m), 7.65 (2H, dd, J = 7.5, 1.0 Hz), 
7.93 (1H, s); 13C NMR (101 MHz, CDCl3į
124.3, 126.2, 126.8, 129.5, 140.1, 141.1, 153.3; FTIR: Ȟmax  2924 (m), 2854 (m), 1599 (m), 
1554 (m), 1503 (s), 1463 (m), 1383 (m), 1219 (m), 1053 (s), 953 (m); HRMS (ESI-TOF) m/z 
[M+H]+ calculated for C17H23N2: 255.1856. Found: 255.1862. 
1-(4-Fluorophenyl)-3-(phenyl)pyrazole, 35a and 1-(4-fluorophenyl)-4-(phenyl)-pyrazole, 
35b:17  
Following general procedure B using N-(4-fluorophenyl)sydnone (200 mg, 1.10 mmol) and 
phenylacetylene (453 mg, 4.44 mmol), an inseparable mixture of pyrazole 35a and 35b was 
isolated as a yellow solid (264 mg, 100%, 9:1).  
1H NMR (400 MHz, CDCl3į+GJ = 2.5 Hz), 7.13-7.21 (2H, m), 7.31-7.38 (1H, 
m), 7.44 (2H, t, J = 7.5 Hz), 7.71-7.77 (2H, m), 7.88-7.94 (3H, m); 13C NMR (101 MHz, 
CDCl3į G J = 23.0 Hz), 121.0 (d, J = 8.5 Hz), 126.0, 128.3, 128.8, 130.2, 
133.1, 136.7, 153.2, 161.2 (d, J = 246.5 Hz); 19F NMR (376 MHz, CDCl3į-116.1. 
1-(4-Fluorophenyl)-3-(phenyl)-4-(4-methoxyphenyl)pyrazole, 36:  
Following general procedure F using pyrazoles 35a and 35b (264 mg, 1.10 mmol), NBS (197 
mg, 1.10 mmol), 4-methoxyphenylboronic acid (253 mg, 1.67 mmol), XPhosPdG2 (87 mg, 
0.11 mmol) and Na2CO3 (353 mg, 3.33 mmol) for 17 hours, pyrazole 36 was isolated as an 
amorphous orange solid (135 mg, 35%).  
1H NMR (400 MHz, CDCl3į+V+GJ = 9.0 Hz), 7.17 (2H, dd, J = 9.0, 
8.5 Hz), 7.25-7.30 (2H, m), 7.33-7.42 (3H, m), 7.62-7.64 (m, 2H), 7.75 (2H, ddd, J = 10.5, 
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5.0, 3.0 Hz), 7.90 (1H, s); 13C NMR (101 MHz, CDCl3įGJ = 
23.0 Hz), 120.7 (d, J = 8.5 Hz), 122.8, 125.1, 126.5, 128.0, 128.5, 130.0, 133.2, 136.5 (d, J = 
2.5 Hz), 150.5, 158.9, 161.2 (d, J = 245.5 Hz); 19F NMR (376 MHz, CDCl3į-116.2 - -116.0 
(m); )7,5Ȟmax  2835 (w), 1556 (m), 1499 (s), 1448 (m), 1290 (m), 1245 (s), 1175 (s), 1027 
(s), 958 (m); HRMS (ESI-TOF) m/z [M+H]+ calculated for C22H18FN2O: 345.1398. Found: 
345.1398. 
1-(4-Methoxyphenyl)-3-(cyclopropyl)pyrazole, 37a and 1-(4-Methoxyphenyl)-4-
(cyclopropyl)pyrazole, 37b:  
Following general procedure B using N-(4-methoxyphenyl)sydnone (200 mg, 1.04 mmol) 
and cyclopropylacetylene (275 mg, 4.16 mmol), an inseparable mixture of pyrazole 37a and 
37b was isolated as a yellow oil (203 mg, 91%, 9:1).  
1H NMR (400 MHz, CDCl3į-0.83 (2H, m), 0.93-1.02 (2H, m), 2.04 (1H, tt, J = 8.5, 5.0 
Hz), 3.83 (3H, s), 6.07 (1H, d, J = 2.5 Hz), 6.94 (2H, d, J = 9.0 Hz), 7.54 (2H, d, J = 9.0 Hz), 
7.68 (1H, d, J = 2.5 Hz); 13C NMR (101 MHz, CDCl3) į 8.2, 9.4, 55.7, 103.6, 114.6, 120.6, 
120.7, 127.5, 156.7, 158.0; FTIRȞmax  3007 (w), 1530 (m), 1512 (s), 1382 (m), 1299 (m), 
1242 (s), 1180 (m), 1108 (m), 1026 (s), 949 (s); HRMS (ESI-TOF) m/z [M+H]+ calculated for 
C13H15N2O: 215.1179. Found: 215.1176. 
1-(4-Methoxyphenyl)-3-(cyclopropyl)-4-(4-trifluoromethylphenyl)pyrazole, 38:  
Following general procedure F using pyrazoles 37a and 37b (191 mg, 0.891 mmol), NBS 
(159 mg, 0.891 mmol), 4-trifluomethylphenylboronic acid (254 mg, 1.34 mmol), XPhosPdG2 
(70 mg, 0.089 mmol) and Na2CO3 (189 mg, 1.78 mmol) for 17 hours, pyrazole 38 was 
isolated as an amorphous orange solid (234 mg, 73%).  
1H NMR (400 MHz, CDCl3į-1.04 (2H, m), 1.06-1.15 (2H, m), 2.00 (1H, tt, J = 8.5, 5.0 
Hz), 3.84 (3H, s), 6.96 (2H, d, J = 9.0 Hz), 7.58 (2H, d, J = 9.0 Hz), 7.67 (2H d, J = 8.5 Hz), 
7.73 (2H d, J = 8.5 Hz), 7.91 (1H, s); 13C NMR (101 MHz, CDCl3į
114.7, 120.7, 121.3 (q, J = 260.5 Hz), 125.7 (q, J = 3.5 Hz), 125.8, 127.9, 128.5 (q, J = 32.5 
Hz), 133.8, 137.1, 152.5, 158.3; 19F NMR (376 MHz, CDCl3į-62.3;  FTIRȞmax  3011 (w), 
2834 (w), 1620 (w), 1522 (s), 1321 (s), 1252 (m), 1163 (m), 1104 (s), 1065 (s), 1021 (s), 956 
(m), 849 (s); HRMS (ESI-TOF) m/z [M+H]+ calculated for C20H18F3N2O: 359.1366. Found: 
359.1376.  
4-[N-(3-Hydroxypropyl)amide]-N-phenylsydnone: 
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To a solution of 4-carboxylic acid-N-phenylsydnone (2.00 g, 9.70 mmol) in CH2Cl2 (50 mL) 
at 0 RC was added oxalyl chloride (3.69 g, 29.1 mmol) and DMF (3 drops) and the mixture 
stirred for 10 minutes at 0 RC. The reaction was allowed to warm to room temperature and 
stirred for a further 3 hours. Volatiles were then removed in vacuo and the resulting yellow 
solid dissolved in CH2Cl2 (50 mL). Triethylamine (982 mg, 9.70 mmol) and 3-aminopropanol 
(874 mg, 11.6 mmol) were added at 0 RC and the reaction stirred for 14 hours at RT. The 
reaction was poured into water, extracted with CH2Cl2, the combined organic layers were 
dried over MgSO4 and volatiles removed in vacuo. The resulting crude material was purified 
by flash silica chromatography (eluting solvent 100% ethyl acetate) affording the title 
compound as a colourless solid (2.00 g, 78%). The product could be further purified by 
recrystallisation from CH2Cl2/petrol. 
M.p.: 84-86 qC; 1H NMR (400 MHz, CDCl3į+WGJ = 12.0, 6.0 Hz), 2.64 (1H, t, J 
= 6.0 Hz), 3.49 (2H, dd, J = 12.0, 6.0 Hz), 3.62 (2H, q, J = 6.0 Hz), 7.53-7.62 (4H, m), 7.68 
(1H, ddt, J = 8.0, 6.5, 1.5 Hz), 7.75 (1H, s); 13C NMR (101 MHz, CDCl3į
)7,5Ȟmax  3449 (br), 3335 (m), 2930 (w), 
1759 (s), 1653 (s), 1534 (s), 1493 (w), 1291 (m), 1215 (m), 956 (m); HRMS (ESI-TOF) m/z 
[M+H]+ calculated for C12H14N3O4: 264.0984. Found: 264.0974. 
4-[2-(5,6-Dihydro-4H-1,3-oxazine)]-N-phenylsydnone: 
To a solution of triphenylphosphine oxide (1.90 g, 6.84 mmol) in CH2Cl2 (35 mL) at 0 RC 
was added triflic anhydride (804 mg, 2.85 mmol) and the reaction stirred for 30 minutes at 0 
RC. A solution of 4-[N-(3-hydroxypropyl)amide]-N-phenylsydnone (500 mg, 1.90 mmol) in 
CH2Cl2 (15 mL) was slowly added at 0 RC and the reaction allowed to warm to room 
temperature and stirred for 14 hours. The reaction mixture was poured into water and the 
organic layer discarded. The aqueous layer was basified with NaHCO3 and extracted with 
ethyl acetate. The combined organic layers were dried over MgSO4 and volatiles removed in 
vacuo. The crude material was purified by flash silica chromatography (eluting solvent 100% 
ethyl acetate) affording the title compound as a colourless solid (243 mg, 52%). 
M.p.: 97-101 qC; 1H NMR (400 MHz, CDCl3į+GWJ = 11.5, 6.0 Hz), 3.47 (2H, t, J 
= 6.0 Hz), 4.04-4.09 (2H, m), 7.47-7.73 (5H, m); 13C NMR (101 MHz, CDCl3į
65.5, 103.0, 124.7, 129.4, 131.9, 135.6, 146.6, 166.2; FTIRȞmax  3061 (w), 2959 (w), 2856 
(w), 1766 (s), 1754 (s), 1657 (s), 1635 (s), 1480 (s), 1437 (m), 1275 (s), 1140 (s), 1078 (s), 
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1024 (s); HRMS (ESI-TOF) m/z [M+H]+ calculated for C12H12N3O3: 246.0879. Found: 
246.0886. 
1-(Phenyl)-3-(cyclopropyl)-5-[2-(5,6-dihydro-4H-1,3-oxazine)]pyrazole, 39a and 1-(phenyl)-
4-(cyclopropyl)-5-[2-(5,6-dihydro-4H-1,3-oxazine)]pyrazole, 39b:  
Following general procedure B using 4-[2-(5,6-dihydro-4H-1,3-oxazine)]-N-phenylsydnone 
(155 mg, 0.632 mmol) and cyclopropylacetylene (167 mg, 2.53 mmol), an inseparable 
mixture of pyrazole 39a and 39b was isolated as an orange oil (29 mg, 91%, 95:5).  
1H NMR (400 MHz, CDCl3į-0.81 (2H, m), 0.85-0.99 (2H, m), 1.82-1.94 (2H, m), 1.99 
(1H, tt, J = 8.5, 5.0 Hz), 3.47 (2H, t, J = 6.0 Hz), 4.07 (2H, t, J = 5.5 Hz), 6.37 (1H, s), 7.26-
7.35 (1H, m), 7.35-7.47 (4H, m); 13C NMR (101 MHz, CDCl3į
105.6, 124.7, 127.4, 128.6, 137.5, 141.0, 150.0, 155.7; FTIRȞmax 2952 (w), 2837 (w), 1664 
(s), 1596 (m), 1543 (m), 1502 (s), 1377 (m), 1338 (m), 1231 (m), 1121 (m), 1097 (s), 994 (s), 
760 (s); HRMS (ESI-TOF) m/z [M+H]+ calculated for C16H18N3O: 268.1444. Found: 
268.1448. 
1-(Phenyl)-3-(cyclopropyl)-4-(4-trifluoromethylphenyl)-5-[2-(5,6-dihydro-4H-1,3-oxazine)]-
pyrazole, 40:  
Following general procedure F using pyrazoles 39a and 39b (27 mg, 0.10 mmol), NBS (18 
mg, 0.10 mmol), 4-trifluomethylphenylboronic acid (29 mg, 0.15 mmol), XPhosPdG2 (8 mg, 
0.01 mmol) and Na2CO3 (32 mg, 0.30 mmol) for 17 hours, pyrazole 40 was isolated as a 
colourless solid (12 mg, 29%).  
1H NMR (400 MHz, CDCl3į-0.95 (2H, m), 1.00-1.06 (2H, m), 1.80-2.92 (3H, m), 3.42 
(2H, t, J = 6.0 Hz), 4.07 (2H, t, J = 5.5 Hz), 7.33 (1H, t, J = 7.5 Hz), 7.43 (2H, t, J = 8.0 Hz), 
7.49-7.56 (2H, m), 7.67 (4H, s); 13C NMR (101 MHz, CDCl3į
65.7, 123.9, 124.5 (q, J = 271.5), 125.2 (q, J = 3.5), 127.6, 129.0, 129.80 (q, J = 36.0), 
129.81, 135.0, 136.6, 140.3, 150.0, 152.4; 19F NMR (376 MHz, CDCl3į-62.4; FTIRȞmax  
2957 (w), 1671 (m), 1619 (m), 1596 (m), 1498 (m), 1381 (m), 1324 (s), 1231 (m), 1162 (s), 
1122 (s), 1069 (s); HRMS (ESI-TOF) m/z [M+H]+ calculated for C23H21F3N3O: 412.1631. 
Found: 412.1636. 
1-(Phenyl)-3-(methanol)-5-(4-tolyl)pyrazole, 41a and 1-(phenyl)-4-(methanol)-5-(4-
tolyl)pyrazole, 41b:  
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Following general procedure B using 4-(4-tolyl)-N-phenylsydnone (200 mg, 0.793 mmol) 
and propargylalcohol (178 mg, 3.17 mmol), an inseparable mixture of pyrazole 41a and 41b 
was isolated as a brown oil (132 mg, 63%, 95:5).  
1H NMR (400 MHz, CDCl3į+V+EU4.78 (2H, s), 6.49 (1H, s), 7.20 
(4H, s), 7.26-7.37 (5H, m); 13C NMR (101 MHz, CDCl3į
127.63, 128.7, 129.1, 129.3, 138.5, 140.1, 144.5, 152.9; FTIRȞmax 3340 (br), 2928 (w), 1596 
(m), 1498 (s), 1442 (m), 1374 (s), 1184 (m), 1035 (s), 1000 (s), 970 (s); HRMS (ESI-TOF) 
m/z [M+H]+ calculated for C17H17N2O: 265.1335. Found: 265.1342. 
1-(Phenyl)-3-(methanol)-4-(4-trifluoromethylphenyl)-5-(4-tolyl)pyrazole, 42:  
Following general procedure F using pyrazoles 41a and 41b (143 mg, 0.541 mmol), NBS (96 
mg, 0.54 mmol), 4-trifluomethylphenylboronic acid (154 mg, 0.812 mmol), XPhosPdG2 (43 
mg, 0.054 mmol) and Na2CO3 (115 mg, 1.08 mmol) for 17 hours, pyrazole 42 was isolated as 
a colourless solid (77 mg, 38%).  
1H NMR (400 MHz, CDCl3į+V+V+GJ = 8.0 Hz), 7.05 (2H, 
d, J = 8.0 Hz), 7.26-7.37 (7H, m), 7.54 (2H, d, J = 8.0 Hz) (OH not observed); 13C NMR (101 
MHz, CDCl3įTJ = 272.0 Hz), 125.35, 125.42 (q, J = 3.5 Hz), 
126.4, 127.7, 128.7 (q, J = 32.5 Hz), 129.0, 129.6, 130.1, 130.2, 136.5, 138.8, 139.7, 141.6, 
150.5; 19F NMR (376 MHz, CDCl3į-62.4; )7,5Ȟmax  3346 (br), 2877 (w), 1618 (w), 1595 
(w), 1496 (m), 1378 (m), 1323 (s), 1166 (m), 1108 (s), 1068 (s), 1018 (m), 1004 (m), 855 (s); 
HRMS (ESI-TOF) m/z [M+H]+ calculated for C24H20F3N2O: 409.1522. Found: 409.1529. 
1-(Phenyl)-3-(cyclopropyl)-5-[(N-methoxy-N-methyl)amide]-pyrazole, 43a and 1-(phenyl)-4-
(cylcopropyl)-5-[(N-methoxy-N-methyl)amide]-pyrazole, 43b:  
Following general procedure B using 4-[(N-methoxy-N-methyl)amide]-N-phenylsydnone 
(150 mg, 0.602 mmol) and cyclopropylacetylene (159 mg, 2.41 mmol), an inseparable 
mixture of pyrazole 43a and 43b was isolated as an orange oil (138 mg, 84%, 9:1).  
1H NMR (400 MHz, CDCl3) 0.78-0.86 (2H, m), 0.92-1.06 (2H, m), 1.95-2.11 (1H, m), 3.17 
(3H, s), 3.52 (3H, s),  6.37 (1H, s), 7.28-7.54 (5H, m); 13C NMR (101 MHz, CDCl3į
)7,5Ȟmax 1648 (s), 
1596 (m), 1544 (m), 1501 (s), 1372 (s), 1307 (m), 1183 (m), 1153 (m), 973 (s), 868 (m); 
HRMS (ESI-TOF) m/z [M+H]+ calculated for C15H18N3O2: 272.1394. Found: 272.1398. 
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1-(Phenyl)-3-(phenyl)-5-(2-pyridyl)pyrazole, 45a and 1-(phenyl)-4-(phenyl)-5-(2-
pyridyl)pyrazole, 45b:  
Following general procedure B using 4-(2-pyridyl)-N-phenylsydnone (200 mg, 0.836 mmol) 
and phenylacetylene (342 mg, 3.34 mmol), an inseparable mixture of pyrazole 45a and 45b 
was isolated as a brown oil (244 mg, 98%, 9:1).  
1H NMR (400 MHz, CDCl3) 7.16-7.23 (2H, m), 7.28-7.54 (8H, m), 7.64 (1H, td, J = 8.0, 1.5 
Hz), 7.94 (2H, d, J = 7.0 Hz), 8.65 (1H, d, J = 4.0 Hz); 13C NMR (101 MHz, CDCl3į
122.9, 123.7, 125.6, 126.0, 127.9, 128.2, 128.8, 129,1, 133.0, 136.5, 139.8, 140.5, 143.6, 
149.8, )7,5Ȟmax 2957 (w), 1587 (m), 1496 (m), 1456 (m), 1441 (m), 1359 (m), 1216 
(w), 1069 (w), 995 (w); HRMS (ESI-TOF) m/z [M+H]+ calculated for C20H15N3: 298.1339. 
Found: 298.1349. 
1-(Phenyl)-3-(phenyl)-4-vinyl-5-(2-pyridyl)pyrazole, 46:  
Following general procedure F using pyrazoles 45a and 45b (244 mg, 0.821 mmol), NBS 
(146 mg, 0.821 mmol), vinyllboronic acid pinacol ester (190 mg, 1.23 mmol), XPhosPdG2 
(65 mg, 0.08 mmol) and Na2CO3 (261 mg, 2.46 mmol) for 17 hours, pyrazole 46 was isolated 
as an amorphous orange solid (106 mg, 40%).  
1H NMR (400 MHz, CDCl3į+GGJ = 11.5, 1.5 Hz), 5.13 (1H, dd, J = 18.0, 1.5 
Hz), 6.69 (1H, dd, J = 18.0, 11.5 Hz), 7.23-7.32 (7H, m), 7.38 (1H, ddd, J = 7.5, 3.5, 1.5 Hz), 
7.42-7.48 (2H, m), 7.66 (1H, td, J = 7.5, 2.0 Hz), 7.73-7.77 (2H, m), 8.70 (1H, dd, J = 5.5, 
1.5 Hz); 13C NMR (101 MHz, CDCl3 į       
128.1, 128.5, 128.9, 129.0, 133.6, 136.5, 139.9, 140.0, 150.1, 150.3, 151.1; FTIRȞmax  2927 
(w), 1592 (m), 1497 (m), 1447 (m), 1419 (m), 1360 (m), 992 (m), 974 (m); HRMS (ESI-
TOF) m/z [M+H]+ calculated for C22H18N3: 324.1495. Found: 324.1507. 
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